Zyn’s FDA Authorization: A Global Marketing Tool for the Tobacco Industry
June 23, 2026
In January 2025, the U.S. Food and Drug Administration authorized legal marketing of Zyn nicotine pouches to adults 21 and older.
The authorization allows marketing, but it “does not mean these tobacco products are safe, nor are they ‘FDA approved’,” according to the ruling.
Philip Morris International and its allies are using the FDA authorization to support the claim that Zyn is a tobacco cessation aid and a harm reduction tool, despite a lack of evidence.
Tobacco control advocates have raised concerns that other governments may follow the FDA’s example and allow marketing and sales in their countries.
